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A B S T R A C T
Background
Various tools exist for initial assessment of possible dementia with no consensus on the optimal assessment method. Instruments that
use collateral sources to assess change in cognitive function over time may have particular utility. The most commonly used informant
dementia assessment is the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE).
A synthesis of the available data regarding IQCODE accuracy will help inform cognitive assessment strategies for clinical practice,
research and policy.
Objectives
Our primary objective was to determine the diagnostic accuracy of the informant based questionnaire IQCODE, for detection of all
cause (undifferentiated) dementia in community-dwelling adults with no previous cognitive assessment. We sought to describe the
accuracy of IQCODE (the index test) against a clinical diagnosis of dementia (the reference standard).
Our secondary objective was to describe the effect of heterogeneity on the summary estimates. We were particularly interested in the
traditional 26-item scale versus the 16-item short form; and language of administration. We explored the effect of varying the threshold
IQCODE score used to define ’test positivity’.
Search methods
We searched the following sources on 28 January 2013: ALOIS (Cochrane Dementia and Cognitive Improvement Group), MEDLINE
(OvidSP), EMBASE (OvidSP), PsycINFO (OvidSP), BIOSIS Previews (ISI Web of Knowledge), Web of Science with Conference
Proceedings (ISI Web of Knowledge), LILACS (BIREME). We also searched sources relevant or specific to diagnostic test accuracy:
MEDION (Universities of Maastrict and Leuven); DARE (York University); ARIF (Birmingham University). We used sensitive search
terms based on MeSH terms and other controlled vocabulary.
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Selection criteria
We selected those studies performed in community settings that used (not necessarily exclusively) the IQCODE to assess for presence
of dementia and, where dementia diagnosis was confirmed, with clinical assessment. Our intention with limiting the search to a
’community’ setting was to include those studies closest to population level assessment. Within our predefined community inclusion
criteria, there were relevant papers that fulfilled our definition of community dwelling but represented a selected population, for example
stroke survivors. We included these studies but performed sensitivity analyses to assess the effects of these less representative populations
on the summary results.
Data collection and analysis
We screened all titles generated by the electronic database searches and abstracts of all potentially relevant studies were reviewed.
Full papers were assessed for eligibility and data extracted by two independent assessors. For quality assessment (risk of bias and
applicability) we used the QUADAS 2 tool. We included test accuracy data on the IQCODE used at predefined diagnostic thresholds.
Where data allowed, we performed meta-analyses to calculate summary values of sensitivity and specificity with corresponding 95%
confidence intervals (CIs). We pre-specified analyses to describe the effect of IQCODE format (traditional or short form) and language
of administration for the IQCODE.
Main results
From 16,144 citations, 71 papers described IQCODE test accuracy. We included 10 papers (11 independent datasets) representing
data from 2644 individuals (n = 379 (14%) with dementia). Using IQCODE cut-offs commonly employed in clinical practice (3.3,
3.4, 3.5, 3.6) the sensitivity and specificity of IQCODE for diagnosis of dementia across the studies were generally above 75%.
Taking an IQCODE threshold of 3.3 (or closest available) the sensitivity was 0.80 (95% CI 0.75 to 0.85); specificity was 0.84 (95%
CI 0.78 to 0.90); positive likelihood ratio was 5.2 (95% CI 3.7 to 7.5) and the negative likelihood ratio was 0.23 (95% CI 0.19 to
0.29).
Comparative analysis suggested no significant difference in the test accuracy of the 16 and 26-item IQCODE tests and no significant
difference in test accuracy by language of administration. There was little difference in sensitivity across our predefined diagnostic cut-
points.
There was substantial heterogeneity in the included studies. Sensitivity analyses removing potentially unrepresentative populations in
these studies made little difference to the pooled data estimates.
The majority of included papers had potential for bias, particularly around participant selection and sampling. The quality of reporting
was suboptimal particularly regarding timing of assessments and descriptors of reproducibility and inter-observer variability.
Authors’ conclusions
Published data suggest that if using the IQCODE for community dwelling older adults, the 16 item IQCODE may be preferable to
the traditional scale due to lesser test burden and no obvious difference in accuracy. Although IQCODE test accuracy is in a range that
many would consider ’reasonable’, in the context of community or population settings the use of the IQCODE alone would result in
substantial misdiagnosis and false reassurance. Across the included studies there were issues with heterogeneity, several potential biases
and suboptimal reporting quality.
B A C K G R O U N D
Dementia is a substantial and growing public health concern (Ferri
2005).Depending on the case definition employed, contemporary
estimates of dementia prevalence in the United States are in the
range of 2.5 to 4.5 million individuals (Hebert 2003). Dementia
is predominantly a disease of older adults, with a 5% prevalence in
adults aged over 60 years, increasing to up to 50% in adults aged
over 85 years (Ferri 2005). Changes in population demograph-
ics will result in increased absolute and proportional numbers of
older adults and will be accompanied by increases in dementia in-
cidence and prevalence, albeit the extent of this increase is debated
(Matthews 2013). Dementia is not limited to ’Western’ nations
and an increasing prevalence is particularly marked in countries
such as China and India (Ferri 2005).
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Given the projected global increase in dementia prevalence, there
is a potential tension between the clinical requirements for robust
diagnosis at the individual patient level and the need for equitable,
easy access to diagnosis at a population level. The ideal would
be expert, multidisciplinary assessment informed by various sup-
plementary investigations. Such an approach may be possible in
a secondary or tertiary care setting, however, in a community or
primary care setting the population is too large and the prevalence
of the disease will be low relative to the more specialist memory-
clinic setting.
In practice a two-stage process is often employed and initial screen-
ing or ’triage’ assessments, suitable for use by non-specialists, are
used to select those patients who require further detailed assess-
ment (Boustani 2003). Various tools for initial cognitive screening
or case finding have been described (Brodaty 2002; Folstein 1975;
Galvin 2005). However, regardless of the methods employed there
is scope for improvement with observational studies suggesting
that many patients with dementia are not diagnosed (Chodosh
2004; Valcour 2000).
Initial assessment often takes the form of brief, direct cognitive
testing. Using this method a single test can only provide a ’snap-
shot’ of cognitive function. However, a defining feature of demen-
tia is cognitive or neuropsychological change over time. Patients
themselves may struggle to make an objective assessment of per-
sonal change over a period of years and so an attractive approach
is to question collateral sources with sufficient knowledge of the
patient. Various terms have been used to describe the person(s)
providing descriptions of the patient’s cognition including proxy,
collateral, informant, carer etc. We should make no assumptions
about the relationship of the person providing the description and
for consistency throughout the text we use the term informant.
Informant-based interviews have been described that aim to ret-
rospectively assess change in function over a period of time. An
instrument prevalent in research and clinical practice is the In-
formant Questionnaire on Cognitive Decline in the Elderly (IQ-
CODE), and this is the focus of our review.
There is no consensus on the optimal test for dementia and choice
of test is currently dictated by experience with a particular instru-
ment, time constraints and training. A better understanding of
the diagnostic properties of various strategies would allow for an
informed approach to testing. Critical evaluation of the evidence
base for short dementia tests or other diagnostic markers is of ma-
jor importance. Without a robust synthesis of the available infor-
mation there is the risk that future research, clinical practice and
policy will be built on erroneous assumptions about diagnostic
validity.
Target condition being diagnosed
The target condition for this diagnostic test accuracy review is
dementia (clinical diagnosis).
Dementia is a syndrome characterised by cognitive or neuropsy-
chological decline sufficient to interfere with usual functioning.
The neurodegeneration and clinical manifestations of dementia
are progressive and at present there is no ’cure’, although numer-
ous interventions to slow or arrest cognitive decline have been
studied.(Birks 2006; Clare 2003; McShane 2006).
Dementia remains a clinical diagnosis, based on a history from
the patient and suitable informant sources and direct examina-
tion including cognitive assessment. Expert committees have de-
scribed criteria for diagnosis of the dementia syndrome and its var-
ious subtypes (Erkinjuntti 2000; McKeith 2005;McKhann 1984;
McKhann 2001; Roman 1993). Various clinical diagnostic pro-
tocols are available and although there are slight variations in Eu-
ropean and American guidance, core features are common to all
diagnostic criteria (McKhann 2011) (Appendix 1).
We recognise that there is no universally accepted, gold standard
dementia diagnostic strategy. We chose expert clinical diagnosis as
our gold standard (reference standard) for describing IQCODE
accuracy as we believe this is most in keeping with current diag-
nostic criteria and best practice. Previous studies have used neu-
ropathology as a gold standard. For the purpose of testing diagnos-
tic accuracy in large unselected populations, limiting analysis to
those studies with neuropathological confirmed diagnosis is likely
to yield limited and highly selected data (Savva 2009). Criteria for
diagnosis of dementia are evolving in line with improvements in
our understanding of the underlying pathophysiological processes.
Various biomarkers based on biological fluid assays or functional
and quantitative neuroimaging have shown promise but to date
they are not accepted or validated as independent diagnostic tests
(McKhann 2011; Noel-Storr 2012).
The label of dementia encompasses varying pathologies of which
Alzheimer’s disease is the most common. For our reference stan-
dard of clinical diagnosis, we accept a dementia diagnosis made ac-
cording to any of the internationally accepted diagnostic criteria,
with exemplars being the various iterations of the World Health
Organization International Classification of Diseases (ICD) and
the American Psychiatric Association Diagnostic and Statistical
Manual of Mental Disorders (DSM) for all cause dementia and
subtypes (Appendix 1). We also recognise the various diagnostic
criteria available for specific dementia subtypes that is the Na-
tional Institute of Neurological and Communicative Disorders
and Stroke and the Alzheimer’s Disease and Related Disorders
Association (NINCDS-ADRDA) criteria for Alzheimer’s demen-
tia (McKhann 1984); McKeith criteria for Lewy Body demen-
tia (McKeith 2005); Lund criteria for frontotemporal dementias
(McKhann 2001); and theNational Institute of Neurological Dis-
orders and Stroke - Association Internationale pour la Recherche
et l’Enseignement enNeurosciences (NINDS-AIREN) criteria for
vascular dementia (Roman 1993). Diagnostic criteria are contin-
ually evolving in line with a better clinical and scientific under-
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standing of dementia, for example at the time of review the fifth
edition of DSM was in pre-release.
Index test(s)
We chose the Informant Questionnaire on Cognitive Decline in
the Elderly (IQCODE) (Jorm 1988) as our index test of interest.
The IQCODE was originally described as a 26-item informant
questionnaire designed to retrospectively ascertain change in cog-
nitive and functional performance over a 10-year time period
(Jorm 1988). IQCODE is designed as a brief assessment for po-
tential dementia, usually administered as a questionnaire given to
the relevant proxy. For each item the chosen proxy scores change
on a five-point ordinal hierarchical scale with responses ranging
from1: “has becomemuch better” to 5: “has becomemuchworse”.
This gives a sum-score of 26 to 130 that can be averaged by the
total number of completed items to give a final score of 1.0 to 5.0,
where higher scores indicate greater decline.
First described in 1989, use of IQCODE is prevalent in both clin-
ical practice and research (Holsinger 2007) and the questionnaire
has been translated into several languages (www.anu.edu.au/iq-
code/). IQCODE has a number of features that make it attractive
for clinical and research use. The questions used have an imme-
diacy and relevance that is likely to appeal to users. Assessment
and (informant) scoring takes around five to seven minutes and
as the scale is not typically interviewer administered it requires
minimal training in application and scoring (Holsinger 2007).
Proponents of IQCODE suggest several potentially favourable
properties of the IQCODE when compared to standard direct
assessments. The IQCODE may be less prone to bias from cul-
tural norms and previous levels of education; the scale has good
inter-rater reliability; and internal consistency is uniformly high
with Cronbach’s alpha in the range 0.93 to 0.97 (Jorm 1989A).
Validation work has included validation against measures of cog-
nitive change; neuropathology; neuroimaging and neuropsycho-
logical assessment (Cordoliani-Mackowiak 2003; Jorm 2000A;
Rockwood 1998).
A shortened 16-item version is available; this modified IQCODE
is common in clinical practice and has been recommended as the
preferred IQCODE format (Jorm 2004). Further modifications
to IQCODE are described including fewer items and assessment
over shorter time periods. For our analysis we chose to include
all versions of IQCODE but present results for the original and
modified scales separately in the first instance. In this text, the term
IQCODE refers to the original 26-item questionnaire as described
by Jorm (Jorm 1988).
IQCODE cut-off scores used to define test positivity vary with
the demographics of the population and the reason for testing.
In the original development and validation work, normative data
were described with a total score of > 93 or average score of >
3.31 indicative of cognitive impairment (Jorm 1988). There is
no consensus on the optimal threshold and various authors have
described improved diagnostic accuracy with other cut-offs.
The full 26 and 16-item versions of ICQODE with scoring rules
are available as appendices (Appendix 2; Appendix 3).
Clinical pathway
A key element of effective management in dementia is robust di-
agnosis. Recent guidelines place emphasis on early diagnosis to fa-
cilitate improved management and to allow informed discussions
and planning with patients and carers. The utility of screening for
an early, unprompted diagnosis of dementia remains a subject of
debate. There are major pressures for early diagnosis from third
sector organisations, patient representative groups, and the phar-
maceutical industry; and in certain countries opportunistic cogni-
tive screening or case-finding is suggested (Brunet 2012; Cordell
2013).
We recognise the importance of healthcare setting and populations
in describing test properties. We have defined a series of settings
and populations for reviews; these are based on the reason for
performing the index (IQCODE) test and the likely prevalence of
dementia.
Studies can be based in secondary care, that is where a referral has
already been made by a healthcare professional and where there
may have been some form of cognitive screening or selection.
In the general practice or primary care setting, patients generally
self-present to a non-specialist service because of subjective mem-
ory complaints, usually with no prior cognitive testing. In this
setting the purpose of cognitive testing is to triag’ individuals to
inform decisions about onward specialist referral.
A study in a community (population) setting will generally be an
unselected cohort with no previous cognitive assessment. The pur-
pose of community cognitive testingmay be population screening,
or to inform epidemiological studies. Our intention with the com-
munity setting was to include those studies closest to population
level screening. Methodologies for selecting representative com-
munity samples differ and for this review we adopted an inclusive
approach in the first instance, including studies where the popu-
lations were community dwelling and not selected on the basis of
cognitive scores or symptoms. We would expect lower prevalence
of disease in the community setting compared to other settings.
This is an important methodological point as in certain studies
researchers ’enrich’ a community population with dementia cases.
This process can artificially improve test accuracy and does not
allow for description of those metrics that relate to population
prevalence, for example positive or negative predictive value.
For this review we described the test accuracy of IQCODE when
used in a community setting. For consistency through the review
we have used the term community. Reviews describing studies in
other settings will also be available in due course.
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Prior test(s)
For a review in a community setting, we would expect that the
majority of individuals included will have had no previous assess-
ment for cognitive problems. We did not include studies where
recruitment was based on results of previous cognitive test(s).
Role of index test(s)
Although we use the term diagnosis in this review, we recognise
that in practice IQCODE alone is not sufficient to make a diag-
nosis. Rather IQCODE is used as an initial case finding, triage, or
screening test that can inform the need for further assessment or
assist with diagnosis in conjunction with direct patient assessment
and investigations. For ease of understanding and consistency with
other reviews we used the term diagnostic accuracy to infer ’accu-
racy of IQCODE test for suggesting a possible dementia case’.
Alternative test(s)
Several other dementia assessment tools have been described, these
are usually performance-based measures that rely on compar-
ing single or multi-domain cognitive testing against population-
specific normative data (Brodaty 2002; Burns 2004; Holsinger
2007). There are fewer informant interviews available. An alter-
native to IQCODE that is popular in North America is the eight-
item Interview to Differentiate Aging and Dementia (AD-8) (
Galvin 2005).
For this review we did not consider other cognitive screening or
assessment tools and have chosen not to include other tests as
comparators. Currently there is no standard practice biomarker or
neuropsychological test and so we felt that making decisions on
meaningful comparators was premature. Where a paper describes
IQCODE with in-study comparison against another tool, we in-
cluded the IQCODE data only. Where the IQCODE code was
used in combinationwith another tool, we included the IQCODE
data only.
Our IQCODE diagnostic studies form part of a larger body of
work describing the test accuracy of all commonly used scales
and Cochrane diagnostic test accuracy (DTA) reviews specific
to the AD-8; Abbreviated Mental Test (AMT); Clock Drawing
Test (CDT);Mini-Cognitive Assessment Instrument (Mini-Cog);
Mini-Mental State Examination (MMSE); Montreal Cognitive
Assessment (MoCA) and General Practitioner assessment of Cog-
nition (GPcog) are planned or in production (Appendix 4).
Rationale
Clinical properties of a dementia test should not be assumed and
formal testing of sensitivity, specificity and other properties of
IQCODE should be performed and collated before the tool can
be recommended.
IQCODE is commonly used in practice and research; it is used
internationally and is one of only a few validated informant-based
tools. Literature describing test accuracy of IQCODE in different
settings is available, although some of these studies have been
modest in size. Thus a systematic review and, if possible, meta-
analysis of the diagnostic test accuracy of IQCODE is warranted.
O B J E C T I V E S
Our primary objective was to determine the diagnostic accuracy of
the informant based questionnaire IQCODE, for detection of all
cause (undifferentiated) dementia in community-dwelling adults
with no previous cognitive assessment. We sought to describe the
accuracy of IQCODE (the index test) against a clinical diagnosis
of dementia (the reference standard).
Secondary objectives
Where data were available, we planned to describe the following.
1. The diagnostic accuracy of IQCODE at various pre-
specified thresholds. We recognize that various thresholds or cut-
off scores have been used to define IQCODE test positive states.
We described the test accuracy of IQCODE for the following
cut-off scores (rounded where necessary): 3.3, 3.4, 3.5, 3.6.
These thresholds have been chosen to represent the range of cut-
offs that are commonly used in practice and research; we have
been inclusive in our choice of cut-off to maximize available data
for review.
2. Accuracy of IQCODE for diagnosis of the commonest
specific dementia subtype, Alzheimer’s disease dementia.
3. Effects of heterogeneity (see below) on the reported
diagnostic accuracy of IQCODE.
Our focused study question, restricting this review to a commu-
nity setting, was designed to remove potential heterogeneity re-
lating to study design and setting. Other sources of heterogeneity
in dementia studies such as treatment, intervention or duration
of follow-up are not applicable to this review and were consid-
ered within the inclusion and exclusion criteria. The properties
of a tool describe the behaviour of the instrument under partic-
ular circumstances. Thus for our assessment of potential sources
of heterogeneity (where data allowed), we collated data on key
features of the study population namely age; features of the index
test, namely language of administration and IQCODE format;
features of the reference standard, namely diagnostic criteria used;
and diagnostic methodology.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
All studies of community-based cohorts were potentially eligible
for the review. As discussed, we used the rubric ’community’ to
include studies of community dwelling older adults, unselected
on the basis of cognitive scores or symptoms.
Many studies that assess test properties use a case control method-
ology. This approach is prone to a number of potential biases and
may give artificially high values for test accuracy. For certain stud-
ies, in particular where populations are ’enriched’ with dementia
cases, case control methodology may be employed but not explic-
itly stated. We elected to include potential case control studies in
our initial screening review of the search results and then assess
studies on a case by case basis. Where case control or study enrich-
ing was employed we did not include these in the summary data
or pool these data with other studies.
Case studies or samples with very small numbers (chosen as 10
participants or less for the purposes of this review) were not in-
cluded.
Participants
All community-dwelling adults (aged over 18 years) were poten-
tially eligible. We suspected that the majority of included partici-
pants in the eligible studies would be aged over 65 years.
Our definition of a community-based study setting was a study
where participants were community dwelling, had not been re-
ferred, had not had extensive cognitive testing and had not self-
presented for assessment of subjective memory problems. We an-
ticipated that studies would largely be of unselected community-
dwelling adults; this cohort is itself heterogeneous. We did not
predefine exclusion criteria relating to the ’case-mix’ of the pop-
ulation studied but assessed applicability for each study. Where a
population was community dwelling and unselected on the basis
of cognition but was potentially not representative of the popu-
lation, for example a study with a focus on stroke-survivors, we
chose to explore the effect of these studies on the findings using
sensitivity analyses.
Index tests
Studies had to include (not necessarily exclusively) IQCODEused
as an informant questionnaire.
IQCODE has been translated into various languages. The proper-
ties of a translated IQCODE in a cohort of non-English speakers
may differ from the properties of the original English language
questionnaire. We collected data on the principle language used
for IQCODE assessment in studies to allow for assessment of het-
erogeneity in relation to language.
Since its original description modifications to the administration
of IQCODE have been described (Jorm 2004). Shorter forms of
informant questionnaires that test fewer domains are available and
properties may differ from the original 26-item IQCODE tool.
We included all such versions of IQCODE but presented separate
analysis limited to the commonest 26 and 16-item versions. A
modified IQCODE for self-assessment has been described. As our
interest was informant interviews, self-assessment IQCODE was
not included in the review (Cullen 2007).
Target conditions
Papers reporting any clinical diagnosis of all cause (unspecified)
dementia were potentially eligible for inclusion. Defining a partic-
ular dementia subtype was not required although where available,
these data were recorded.
Reference standards
Our reference standard was clinical diagnosis of dementia. We
recognise that clinical diagnosis itself has a degree of variability but
this is not unique to dementia studies and does not invalidate the
basic diagnostic test accuracy approach. Our definition of clini-
cal diagnosis included all cause (unspecified) dementia, using any
recognised diagnostic criteria (for example ICD-10; DSM-IV).
The dementia diagnosis could specify a pathological subtype and
all dementia subtypes were included (examples McKeith 2005;
McKhann 1984; McKhann 2001; Roman 1993). Clinicians may
have used imaging, pathology or other data to aid diagnosis, how-
ever, diagnosis based only on these data without corresponding
clinical assessment were not included. We recognise that different
iterations of diagnostic criteriamay not be directly comparable and
that diagnosis may vary with the degree or manner in which the
criteria have been operationalised (for example individual clinician
versus algorithm versus consensus determination) and so data on
method and application of dementia diagnosis was collected for
each study.
We did not set criteria relating to severity or stage of dementia
diagnosis, instead any clinical diagnosis of dementia (not mild
cognitive impairment or its equivalents)was classified.Weplanned
to explore stage or severity of dementia as a potential source of
heterogeneity.
Search methods for identification of studies
Weused a variety of information sources to ensure all relevant stud-
ies were included. Terms for electronic database searching were
devised in conjunction with the Trials Search Co-ordinator at the
Cochrane Dementia and Cognitive Improvement Group. As part
of a body of work looking at cognitive assessment tools, we cre-
ated a sensitive search strategy designed to capture dementia test
accuracy studies. The output of the searches was then assessed to
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select those papers that could be pertinent to IQCODE, with fur-
ther selection for directly relevant papers and those papers with a
community (population) focus.
Electronic searches
We searched ALOIS, the specialised register of the Cochrane
Dementia and Cognitive Improvement Group (which includes
both intervention and diagnostic accuracy studies), MEDLINE
(OvidSP), EMBASE (OvidSP), PsycINFO (OvidSP), BIOSIS
(OvidSP), ISI Web of Science and Conference Proceedings
(ISI Web of Knowledge), CINAHL (EBSCOhost) and LILACS
(BIREME). See Appendix 5 and Appendix 6 for the search strate-
gies. The final search date was 28 January 2013.
We also searched sources specific to diagnostic accuracy andhealth-
care assessment:
• MEDION database (Meta-analyses van Diagnostisch
Onderzoek: www.mediondatabase.nl);
• DARE (Database of Abstracts of Reviews of Effects via The
Cochrane Library);
• HTA Database (Health Technology Assessments Database
via The Cochrane Library);
• ARIF database (Aggressive Research Intelligence Facility:
www.arif.bham.ac.uk).
We did not apply any language or date restrictions to the electronic
searches. Translation services were used as necessary.
Initial screening of the search results was performed by a single re-
searcher from the Cochrane Dementia and Cognitive Impairment
Group with extensive experience of systematic reviews (ANS). All
subsequent assessments of search results, based either on assess-
ment of titles, abstracts or full text, were performed by indepen-
dent paired assessors (TQ, PF).
Searching other resources
Grey literature: ’grey’ literature was identified through searching
conference proceedings on EMBASE (OvidSP) and through the
ISI Web of Knowledge platform.
Handsearching: we did not perform handsearching. The evidence
base on handsearching for DTAs is not yet known and there is no
clear guidance on whether handsearching is worthwhile.
Reference lists: we checked the reference lists of all relevant studies
and reviews in the field for further possible titles and repeated the
process until no new titles were found (Greenhalgh 2005).
Correspondence: we contacted research groups who have pub-
lished or are conducting work on the IQCODE for dementia di-
agnosis, informed by results of the initial search.
Relevant additional studies were searched for in PubMed using
the related article feature. Relevant studies were examined in the
citation databases of Science Citation Index and Scopus to ascer-
tain any further relevant studies.
Data collection and analysis
Selection of studies
One review author (ANS) screened for relevance all titles gener-
ated by the initial electronic database searches. The initial search
was a sensitive, generic search designed to include many potential
dementia screening tools. Titles potentially relevant to IQCODE
were selected by two review authors (ANS, TQ). All further re-
views of studies and selection were performed by two independent
researchers (TQ, PF). The potential IQCODE related titles were
reviewed and all eligible studies were assessed as abstracts; poten-
tially relevant studies were assessed against inclusion criteria as full
manuscripts. Disagreement was resolved by discussion, with po-
tential to involve a third author (DJS) as arbitrator if necessary.
We adopted a hierarchical approach to exclusion, first excluding
studies on the basis of index test and reference standard and then
on the basis of sample size and study data. Finally, we assessed all
IQCODE papers with regard to setting.
Where a study may have included useable data but these were not
presented in the publishedmanuscript (labelled as data not suitable
for analysis on flowchart), we contacted the authors directly to
request further information. If the same data set was presented in
more than one paper we included the primary paper.
Wedetailed the study selectionprocess in aPRISMAflowdiagram.
Data extraction and management
Data were extracted to a study-specific pro forma that included
clinical and demographic details of the participants; details of IQ-
CODE administration; and details of the dementia diagnosis pro-
cess. The pro forma was piloted against two of the included papers
before use.
Where IQCODE data were given for a number of cut-points, we
extracted data for each of our pre-specified cut-points: 3.3, 3.4,
3.5, 3.6. Where thresholds were described to two decimal places,
we chose the cut-point closest to the point of interest (that is all
scores less than 3.35 would be scored as 3.3; all scores 3.35 or
greater would be scored as 3.4. Data were extracted to a standard
two by two table.
Data extraction was performed independently by review authors
(TQ, PF). Authorswere based indiffering centres andwere blinded
to each other’s data until extraction was complete.Data pro formas
were then compared and discussed with reference to the original
papers. Disagreement in data extraction was resolved by discus-
sion, with the potential to involve a third author (DJS) as arbitra-
tor if necessary.
For each included paper, the flow of participants (numbers re-
cruited, included, assessed) was detailed in a flow diagram.
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Assessment of methodological quality
As well as describing test accuracy, an important goal of the di-
agnostic test accuracy (DTA) process is to improve study design
and reporting in dementia diagnostic studies. For this reason we
assessed both methodological and reporting quality.
Quality of study reporting was assessed using the STARD check-
list (Bossuyt 2003) (Appendix 7). We recognise that a dementia-
specific extension to complement STARD (STARDdem) (http://
starddem.org/) is proposed, however the content of STARDdem
was not finalised at the time of this analysis. STARD data were
tabulated and presented as an appendix to the review.
We assessed the methodological quality of each study using the
QUADAS-2 tool (http://www.bris.ac.uk/quadas/quadas-2) (Ap-
pendix 8). This tool incorporates domains specific to patient selec-
tion; index test; reference standard; and patient flow. Each domain
is assessed for risk of bias and the first three domains are also as-
sessed for applicability. Operational definitions describing the use
of QUADAS-2 are detailed in Appendix 8. To create QUADAS-2
anchoring statements specific to studies of dementia test accuracy,
we convened a multidisciplinary review of various test accuracy
studies with a dementia reference standard (Appendix 9).
Both assessments were performed by paired independent raters
(TJQ, PF) who were blinded to each other’s scores. Disagreement
was resolved by further review and discussion with the potential
to involve a third author (DJS) as arbitrator if necessary.
QUADAS-2 data were not used to form a summary quality score,
rather we chose to present a narrative summary describing the
numbers of studies that found high, low or unclear risk of bias
and concerns regarding applicability with corresponding tabular
and graphical displays.
Statistical analysis and data synthesis
We were principally interested in the test accuracy of IQCODE
for the dichotomous variable dementia or no dementia. Thus, we
applied the current DTA framework for analysis of a single test to
fit the extracted data to a standard two by two table showing bi-
nary test results cross-classified with the binary reference standard.
This process was repeated for each of our pre-specified IQCODE
threshold scores.
We used RevMan 5.2 (RevMan 2011) to calculate sensitivity,
specificity and their 95% confidence intervals (CIs) from the two
by two tables abstracted from the included studies. These datawere
presented graphically in forest plots to allow basic visual inspec-
tion of individual studies only. Standard forest plots with graphical
representation of summary estimates are not suited to quantita-
tive synthesis of DTA data. Using software additional to RevMan
(SAS release 9.1) we used the bivariate method to calculate sum-
mary values within each pre-specified cut-off. The bivariate meth-
ods (Reitsma 2005) enabled us to calculate summary estimates of
sensitivity and specificity while correctly dealing with the differ-
ent sources of variation: (1) imprecision by which sensitivity and
specificity have been measured within each study; (2) variation
beyond chance in sensitivity and specificity between studies; (3)
any correlation that might exist between sensitivity and specificity.
The results for each chosen threshold were described as sensitiv-
ity and specificity and all accuracy measures were estimated with
their 95% CI. Where data allowed, we chose to present individual
study results graphically by plotting estimates of sensitivities and
specificities in the receiver operating characteristic (ROC) space.
We also described metrics of pooled positive and negative likeli-
hood ratios. To allow an overview of IQCODE test accuracy we
performed a further analysis: pooling data at a common threshold
(3.3 or closest), chosen to maximise the data available for inclu-
sion.
The presence of statistical heterogeneity was assessed by visual
inspection of the included study results plotted in the ROC space
relative to the putative summary accuracy estimates.
Investigations of heterogeneity
Heterogeneity is expected inDTA reviews and we did not perform
formal analysis to quantify heterogeneity.
The properties of a tool describe the behaviour of the instrument
under particular circumstances. Thus, for our assessment of po-
tential sources of heterogeneity (where data allowed) we collected
data to inform two broad pre-specified areas of interest. These
were:
• clinical criteria used to reach dementia diagnosis (for
example ICD-10; DSM-IV) and the methodology used to reach
the dementia diagnosis (e.g. individual assessment; group
(consensus) assessment);
• technical features of the testing strategy (version of
IQCODE (language); numbers of items, that is short form of
IQCODE or long form).
Where data allowed we performed pooled analysis with these fac-
tors as covariates and compared results of subgroups. We pre-spec-
ified that we would present data from the traditional (26 ques-
tions) and short form (16 questions) IQCODE separately.
Sensitivity analyses
Where appropriate (that is if not already explored in our analy-
ses of heterogeneity) and as data allowed, we planned to explore
the sensitivity of any summary accuracy estimates to aspects of
study quality guided by the anchoring statements developed in our
QUADAS-2 exercise. We pre-specified sensitivity analysis where
we planned to exclude studies of low quality (high likelihood of
bias) to determine if the results are influenced by inclusion of the
lower quality studies; and sensitivity analysis excluding studies that
may have unrepresentative populations.
R E S U L T S
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Results of the search
Our search resulted in 16144 citations, of which 71 full text papers
were assessed for eligibility.
We excluded61papers (Figure 1). Reasons for exclusionwere: pop-
ulation not from a community (population) setting; no IQCODE
data or unsuitable IQCODEdata; small numbers of included par-
ticipants; no clinical diagnosis of dementia; repeat data sets; data
not suitable for analysis (Characteristics of excluded studies).
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Figure 1. Study flow diagram.
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Eight studies that were identified required translation, these papers
were not suitable for this review but the data have been used for
reviews of IQCODE in other healthcare settings. We contacted
14 authors to provide useable data, of whom 10 responded. These
datawere not suitable for this (community setting) review but have
been used for other IQCODE analyses in this family of reviews
(see Acknowledgements).
This review included 10 studies representing 11 data sets (n =
2644 participants) (Summary of findings 1; Summary of findings
2; Summary of findings 3).
Methodological quality of included studies
We described risk of bias using the QUADAS 2 methodology
(Appendix 8).
No study was graded low risk of bias for all the categories of
QUADAS-2 (Figure 2; Figure 3). Areas of particular concern for
bias were around: participant sampling procedures (n = 2 papers
graded low risk, with few papers using a true consecutive sampling
frame) and application of index test (n = 1 paper graded low risk
of bias, with most papers giving insufficient detail on how the
IQCODE was actually applied in practice). There were also con-
cerns around applicability, particularly concerning patient selec-
tion procedures (n = 1 paper graded no concern, with few studies
recruiting a cohort representative of community-dwelling older
adults).
Figure 2. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies.
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Figure 3. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study.
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We described reporting quality using the STARD guidance (Ap-
pendix 7). One paper (Yamada 2011) was not included in this
process as we had an expanded conference abstract or poster and
a paper describing the study methodology (Yamada 2008) but a
full manuscript with IQCODE data had not yet been published.
There were limitations in reporting across all included papers (Ap-
pendix 10). No paper included all the details recommended in the
STARD statement; particular areas of study reporting that could
be improved were: reporting of timing of the index test and ref-
erence standard (n = 1 paper reported when the IQCODE was
performed in relation to the diagnostic evaluation); handling of
indeterminate results (n = 0 papers reported, for example, how
incomplete IQCODE questionnaires were handled); and describ-
ing variability between assessors (n = 2 papers reported data on
interobserver variability for index test or reference standard).
Findings
The individual included studies have been described in detail in
Characteristics of included studies and Table 1; we have also pre-
sented tabulated data for test accuracy by covariate (Summary of
findings 2) and formof IQCODE threshold (Summary of findings
3). The total number of participants across the studies was 2644
(range: 37 to 684), of whom 379 (14%) had a clinical dementia
diagnosis. The scope of the included studies was international; in-
cluded data sets were from six countries (Australia, Canada, Japan,
Spain, Sri Lanka and Thailand) (Appendix 11).
Certain papers contained more than one data set. For one paper
the data sets were independent (one urban, one rural) and so we
included these as separate entries (Morales 1997 (urban); Morales
1997 (rural)). One study had a single population assessed by two
independent assessors (one with neurology training and one with
psychiatry training). We used data from only one assessor for our
analysis (Jorm 1996 (psychiatry), favouring the data closest to the
expected population dementia prevalence.
Ten different versions of IQCODE were used in the included
studies (Appendix 11) and eight different diagnostic thresholds
(3.0, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 4.0) were used to define a posi-
tive IQCODE. We limited our analysis to the validated forms of
IQCODE that are in common clinical use, that is the 26 and 16-
item questionnaires.
Within the pre-specified thresholds chosen for analysis there was
a spread of sensitivity and specificity (sensitivity range: 44% to
92%; specificity range: 55% to 96%).
IQCODE (combined 16 and 26-item questionnaire)
Overview analysis - IQCODE using a 3.3 threshold or closest
Across 10 studies there were 11 data sets that contained relevant
data (n = 2644). Sensitivity was 0.80 (95%CI 0.75 to 0.85); speci-
ficity 0.85 (95% CI 0.78 to 0.90). The overall positive likelihood
ratio was 5.27 (95% CI 3.7 to 7.5) and the negative likelihood
ratio was 0.23 (95% CI 0.19 to 0.29).
The summary ROC curve describing test accuracy across the in-
cluded studies is presented in Figure 4.
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Figure 4. Summary ROC Plot, IQCODE using a 3.3 threshold score or nearest.The dark point is a summary
point, the broken line represents 95% CI
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IQCODE 3.3 threshold or closest - comparing 26 and 16-
item IQCODE
We used the overview data set to examine the effect of hetero-
geneity relating to IQCODE format (traditional 26-item or short
form 16-item).
Analysis of the studies using the 26-item IQCODE (n = 7 data
sets) gave sensitivity of 0.80 (95% CI 0.73 to 0.85); specificity
0.86 (95% CI 0.74 to 0.95). The overall positive likelihood ratio
was 5.6 (95% CI 3.4 to 9.1) and the negative likelihood ratio was
0.24 (95% CI 0.18 to 0.31).
Analysis of studies using the 16-item IQCODE (n = 5 data sets)
gave sensitivity of 0.80 (95% CI 0.74 to 0.85); specificity 0.82
(95% CI 0.70 to 0.89). The overall positive likelihood ratio was
4.2 (95% CI 2.6 to 6.8) and the negative likelihood ratio was 0.24
(95% CI 0.10 to 0.65).
Comparing the two there was no difference in accuracy, with a
relative sensitivity of the 26-item versus 16-item IQCODEof 1.00
(95% CI 0.91 to 1.11) and relative specificity 0.94 (95% CI 0.82
to 1.09) (Figure 5).
15Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling
populations (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 5. Summary ROC plot of IQCODE 3.3 threshold or nearest, comparing short form (16 item) and
traditional IQCODE.
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As there was no difference we presented further data as the com-
bined (26 and 16-item IQCODE together) test accuracy.
IQCODE 3.3 threshold or closest - comparing English and
non-English language IQCODE
We coded the language of IQCODE administration as a covariate.
Study numbers did not allow analysis by individual languages and
so we compared the IQCODE in the original wording (English
language) with all translated IQCODE forms (non-English lan-
guage).
Analysis of studies using English language IQCODE (n = 5 data
sets) gave sensitivity of 0.78 (95% CI 0.69 to 0.85); specificity
0.77 (95% CI 0.63 to 0.86). The overall positive likelihood ratio
was 6.7 (95% CI 4.6 to 9.7) and the negative likelihood ratio was
0.28 (95% CI 0.20 to 0.41).
Analysis of studies using non-English language IQCODE (n = 7
data sets) gave sensitivity 0.80 (95% CI 0.74 to 0.85); specificity
0.88 (95% CI 0.82 to 0.92). The overall positive likelihood ratio
was 6.7 (95% CI 4.6 to 9.7) and the negative likelihood ratio was
0.13 (95% CI 0.08 to 0.24).
Comparing the two there was no difference in accuracy, with a
relative sensitivity of 1.03 (95% CI 0.91 to 1.16) and relative
specificity of 1.15 (95% CI 0.98 to 1.34) (Figure 6).
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Figure 6. Summary ROC Plot of pooled IQCODE data at a 3.3 threshold (or nearest value), with language
as covariate.The dark point is a summary point, the broken line represents 95% CI
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As there was no significant difference between groupswe presented
the data (all languages) for each of our pre-specified thresholds.
IQCODE test accuracy at differing diagnostic thresholds
We calculated test accuracy at our pre-specified IQCODE thresh-
olds. We chose to present a summary ROC curve for those analy-
ses with greater than three included studies.
IQCODE 3.3 threshold: there were six data sets* (n = 1232) that
contained relevant data. The sensitivity was 0.83 (95% CI 0.74 to
0.90); specificity 0.80 (95% CI 0.70 to 0.88). The overall positive
likelihood ratio was 4.25 (95% CI 2.75 to 6.56) and the negative
likelihood ratio was 0.21 (95% CI 0.14 to 0.32) (Figure 7).
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Figure 7. Summary ROC Plot of combined(16 and 26 item) IQCODE data using a 3.3 threshold score.The
dark point is a summary point, the broken line represents 95% CI
IQCODE 3.4 threshold: there were three data sets* (n = 988) that
contained relevant data. The sensitivity was 0.84 (95% CI 0.70 to
0.93); specificity 0.80 (95% CI 0.65 to 0.90). The overall positive
likelihood ratio was 4.42 (95% CI 2.47 to 7.90); the negative
likelihood ratio was 0.19 (95% CI 0.10 to 0.35).
IQCODE 3.5 threshold: there were three data sets* (n = 1144)
that contained relevant data. Sensitivity was 0.82 (95%CI 0.75 to
0.87); specificity 0.84 (95% CI 0.80 to 0.88). The overall positive
likelihood ratio was 5.09 (95% CI 4.08 to 6.33); the negative
likelihood ratio 0.22 (95% CI 0.16 to 0.29).
IQCODE 3.6 threshold: there were three studies (n = 1215) that
contained relevant data. Sensitivity was 0.78 (95% CI 0.68 to
0.86); specificity was 0.87 (95% CI 0.71 to 0.95). The overall
positive likelihood ratio was 6.00 (95% CI 2.72 to 13.26); the
negative likelihood ratio was 0.25 (95% CI 0.18 to 0.34).
* Certain papers included more than one data set
Heterogeneity relating to dementia diagnosis
A quantitative analysis of the effect of dementia diagnosis criteria
(reference standard) was not possible as all but one (Jorm 1996
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(psychiatry) of the studies that specified the approach to dementia
diagnosis used the American Psychiatric Association Diagnostic
and Statistical Manual of Mental Disorders (DSM) to define the
dementia state. The remaining study used the World Health Or-
ganization (WHO) International Statistical Classification of Dis-
eases andRelatedHealth Problems (ICD) for diagnosis. This study
also comparedneurologists’ andpsychiatrists’ diagnoses against the
IQCODE and found that IQCODEwasmore sensitive compared
to a psychiatrist’s diagnosis of dementia (Jorm 1996 (psychiatry).
A further original aim was to describe the accuracy of the IQ-
CODE for diagnosis of Alzheimer’s disease dementia. We were
unable to assess this based on the available data as only one study
defined specific dementia diagnoses (Law 1995); all other studies
described the accuracy of IQCODE for diagnosis of all cause de-
mentia only.
Other sources of heterogeneity and sensitivity analyses
One study was of community-dwelling stroke-survivors (Srikanth
2006); we performed a sensitivity analysis by removing these data
from our pooled estimates. We found little difference in test accu-
racy when this study was removed (at a 3.3 threshold, sensitivity
0.81, 95%CI 0.73 to 0.87; specificity 0.81, 95%CI 0.70 to 0.85).
Weperformed a sensitivity analysis removing studieswith a ’young’
population.Not all studies provided data on the age of participants
and descriptive metrics differed across the papers (Table 2). Two
authors (TJQ, PF) reviewed the ages of the included populations
and concluded that one study contained a ’younger’ cohort likely
to meet our pre-specified arbitrary cut-off of more than 20% aged
less than 65 years (Senanorong 2001; see Table 2). This study also
had an unusually high prevalence of dementia suggesting that a
case-control methodology was employed, although this was not
explicitly stated in the paper. We performed a sensitivity analysis
excluding this study. Test accuracies at thresholds of 3.4 and 3.5
were similar after exclusion of this study (sensitivity 0.82, 95%
CI 0.72 to 0.89; specificity 0.79, 95% CI 0.66 to 0.89 at a 3.4
cut-point; sensitivity 0.82, 95% CI 0.74 to 0.88; specificity 0.83,
95% CI 0.78 to 0.87 at a 3.5 cut-point).
Given themodest numbers of papers and the clinical heterogeneity
we did not perform any further sensitivity analysis by QUADAS-
2 metrics or other factors.
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Summary of findings
Study ID Country Subjects (n) IQCODE version Language Dementia diagnosis Dementia prevalence N (%) Other assessments
Jorm 1994 Australia 684 26 & 16 item English DSM IIIr n=52 8% -
Jorm 1996
(psychiatry)
Australia 144 26 & 16 item English ICD9 n=11 8% MMSE
Kathriarachi 2001 Sri Lanka 37 26 item Sinhalese ‘ ‘ clinical assess-
ment’’
n=14 38% MMSE, CDR
Law 1995 Canada 237 26 item French DSM IIIr n=32 14% MMSE
Mackinnon 2003 Australia 646 16 item English DSM IIIr n=36 6% MMSE
Morales 1995 Spain 68 26 & 17 item Spanish DSM IIIr n=7 10% MMSE
Morales 1997
(rural)
Spain 160 26 item Spanish DSM IIIr n=23 14% MMSE
Morales 1997
(urban)
Spain 97 26 item Spanish DSM IIIr n=11 11% MMSE
Senanorong 2001 Thailand 160 16 & 3 item Thai DSM IV n=73 46% TMSE
Srikanth 2006 Australia 79 16 item English DSM IV n=8 10% S-MMSE
Yamada 2011 Japan 423 26 item Japanese DSM IV n=112 26%
See Characteristics of included studies for more detailed study descriptors.
Abbreviations: DSM - American Psychiatric Associationm Diagnostic and Statistical Manual of Mental Disorders; MMSE - Mini Mental
State Examination; AMT - Abbreviated Mental Test; CDR - Clinical Dementia Rating Scale; TMSE - Thai Mental State Exam; S-MMSE -
standardised Mini Mental State Examination.
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4 What is the accuracy of the Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE) test for detection of dementia using
different versions of IQCODE and using different languages of administration
Population Community-dwelling older adults, with no restrictions placed on case-mix of included cohort
Setting ’Community’ setting; this setting was intended to represent a population screening context. Many of
the included studies, although fulfilling our pre-specified inclusion criteria, were of selected population
groups (for example stroke-survivors; ex-prisoners of war) the effect of these studies is described in the
’heterogeneity’ section of results
Index test Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE) administered to a relevant informant.
We restricted analyses to the traditional 26-item IQCODE and a commonly used short form IQCODE with 16
items
Reference Standard Clinical diagnosis of dementia made using any recognised classification system
Studies Cross-sectional studies were included, we did not include case-control studies
Comparative analyses
Test No. of participants (stud-
ies)
Dementia prevalence
total across studies
Findings Implications
26 item versus 16 item
IQCODE
Total: n=2644
(10 studies, 11 data sets)
26 item n=1075 (7 stud-
ies, 8 datasets)
Total n=379
(14%)
26 item n=210
(20%)
16 item n=169
(11%)
No difference in accu-
racy.
Relative sensitivity of 26-
item versus 16-item IQ-
CODE: 1.00 (95% CI 0.91
to 1.11)
Relative specificity of 26
item versus 16-item IQ-
CODE: 0.94 (95% CI 0.82
to 1.09)
Short form IQCODE may
be preferred as lesser test
burden with similar accu-
racy
English language versus
non-English
Total: n=2644
(10 studies, 11 data sets)
English: n=1553
(4 studies)
Total: n=379
(14%)
English: n=107
(6%)
Non-English: n=272
(25%)
No significant difference
in accuracy.
Relative sensitivity of En-
glish language versus
non-English language: 1.
03 (95% CI 0.91 to 1.16)
Relative specificity of En-
glish language versus
non-English language: 1.
15 (95% CI 0.98 to 1.34)
IQCODE accuracy is not
substantially influenced
by language of adminis-
tration
CAUTION: The results on this table should not be interpreted in isolation from the results of the individual included studies contributing
to each summary test accuracy measure. These are reported in the main body of the text of the review
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What is the accuracy of the Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE) test for detection of dementia when
differing thresholds are used to define IQCODE positive cases
Population Community-dwelling older adults, with no restrictions placed on case-mix of included cohort
Setting ’Community’ setting; this setting was intended to represent a population screening context. Many of
the included studies, although fulfilling our pre-specified inclusion criteria, were of selected population
groups (for example stroke-survivors; ex-prisoners of war) the effect of these studies is described in the
’heterogeneity’ section of results
Index test Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE) administered to a relevant informant.
We restricted analyses to the traditional 26-item IQCODE and a commonly used short form IQCODE with 16
items
Reference Standard Clinical diagnosis of dementia made using any recognised classification system
Studies Cross-sectional studies were included, we did not include case-control studies
Test Summary accuracy
(95%CI)
No. of participants (stud-
ies)
Dementia prevalence Implications
Quality and comments
IQCODE cut-off 3.3 or
nearest
sensitivity: 0.80
(95% CI 0.75 to 0.85)
specificity: 0.85
(95% CI 0.78 to 0.90)
positive LR: 5.27
(95% CI 3.70 to 7.50)
negative LR: 0.23
(95% CI 0.19 to 0.29)
n=2644
(10 studies, 11 datasets)
n=379
(14%)
There is no obvious preferred
cut-off for IQCODE accuracy,
within the threshold values
commonly used in clinical
practice and research
So we focus on the summary
data
across all cut-points.
The dementia prevalence
across studies
is higher than would be ex-
pected
for this population.
Using the accuracy figures
re-calculating for a typical
population;
In the UK 9.9 million people
are aged over 65,
current estimates are of
around 6.6% dementia
prevalence.
At the IQCODE accuracy cal-
culated,
using IQCODE alone to
‘ ‘ screen’’ for dementia
would result in:
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87,120 people with dementia
not being picked up
and 1,314,660 dementia free
people being given a possible
diagnosis of dementia
IQCODE cut-off 3.3 sensitivity: 0.83
(95% CI 0.74 to 0.90)
specificity: 0.80
(95% CI 0.70 to 0.88)
positive LR: 4.25
(95% CI 2.75 to 6.56)
negative LR: 0.21
(95% CI 0.14 to 0.32)
n=1232
(5 studies, 6 datasets)
n=112 (9%)
IQCODE cut-off 3.4 sensitivity: 0.84
(95% CI 0.70 to 0.93)
specificity: 0.80
(95% CI 0.65 to 0.90)
positive LR: 4.25
(95% CI 2.47 to 7.90)
negative LR: 0.19
(95% CI 0.10 to 0.35)
n=988
(3 studies)
n=136 (14%)
IQCODE cut-off 3.5 sensitivity: 0.82
(95% CI 0.75 to 0.87)
specificity: 0.84
(95% CI 0.80 to 0.88)
positive LR: 5.09
(95% CI 4.08 to 6.33)
negative LR: 0.22
(95% CI 0.16 to 0.29)
n=1144
(3 studies)
n=178 (16%)
IQCODE cut-off 3.6 sensitivity: 0.78
(95% CI 0.68 to 0.86)
specificity: 0.87
(95% CI 0.71 to 0.95)
positive LR: 6.00
(95% CI 2.72 to 13.26)
negative LR: 0.25
(95% CI 0.18 to 0.34)
n=1215
(3 studies)
n=180 (15%)
CAUTION: The results on this table should not be interpreted in isolation from the results of the individual included studies contributing
to each summary test accuracy measure. These are reported in the main body of the text of the review
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D I S C U S S I O N
Summary of main results
We offer a synthesis of the published data describing the accuracy
of the IQCODE questionnaire tool for detection of dementia
within community-dwelling populations.
Our results suggests that although the IQCODE has reasonable
test properties, for example the positive likelihood ratio of around
5 and negative likelihood ratio of around 0.2 are classically inter-
preted as indicative of a ’moderately good test’, the test alone may
not be suited for dementia screening within community dwelling
older adults.
For a clinical assessment the preferred pattern of diagnostic test ac-
curacy (DTA), optimising sensitivity versus optimising specificity,
will vary with the purpose of the test. The utility and limitations of
screening all community-dwelling older adults for cognitive prob-
lems is a topic that is attracting considerable international debate.
Our data show that even for a ’good’ initial assessment like IQ-
CODE, at a population level the number of false positives and
false negatives is still considerable. Applying our summary data to
a population such as the UK, where 9.2 million adults are aged
over 65 and 6.6% (435,600) of this group may have dementia, we
see that even modest problems in test accuracy can be associated
with considerable numbers of false diagnoses or false reassurance
at population level (using these population numbers and at sensi-
tivity of 0.80 / specificity of 0.84 we find false positive numbers
of around 1314,660; false negative numbers of around 87,120).
We appreciate that in practice the use of such tests is more prag-
matic, but we give this example to illustrate the potential effects
of IQCODE screening at a population level.
Accepting that IQCODE is a reasonable initial test, albeit is per-
haps not sufficient as a single screening test, our pre-specified anal-
yses around heterogeneity were designed to provide guidance on
optimal IQCODE administration with specific reference to form
of IQCODE; language of IQCODE and preferred test positive
cut-point.
There was little difference in sensitivity across the predefined di-
agnostic cut-points. We had expected a more pronounced ’trade-
off ’ between sensitivity and specificity at differing thresholds. Pos-
sible explanations are that the thresholds are too close together to
see differences in accuracy between neighbouring cutoffs or that
any differences are lost in between study heterogeneity. We can
conclude that at the IQCODE values commonly described in re-
search, there is little to choose between the thresholds. There was
a suggestion that sensitivity began to fall at cut-points above 3.5
and a trend towards improved specificity with increasing cut-point
from 3.3 to 3.6. It would seem intuitive that scores above and
below these values would have a more marked difference in sensi-
tivity to specificity ratio. In certain situations, for example in de-
mentia screening where specificity may be preferred to avoid false
positive diagnosis, a cutoffs below 3.3 may be preferred. However,
we found few published studies describing thresholds less than 3.3
or greater than 3.6 and so at present this hypothesis is speculative.
There were many differing forms of IQCODE application de-
scribed across the included papers. We pre-specified a comparative
analysis of IQCODE when used with the traditional 26 questions
and a short form with 16 questions. As the tools had similar ac-
curacy we believe pooling data across these two IQCODE for-
mats was valid. There were insufficient data to describe accuracy
of IQCODE assessments that did not use the standard 26 or 16
item questionnaires and we were wary of describing test accuracy
of unvalidated IQCODE based assessments.
The other area of heterogeneity in IQCODE application was for
language of administration. There were insufficient numbers of
papers to allow a valid analysis of the effect of individual languages
of IQCODE, however summary analysis using dichotomised lan-
guage (’English’ or ’non-English’) as a covariate suggested no sig-
nificant difference. Although not reaching significance, there was
a trend towards differing accuracy. The effect was not as ex-
pected with the non-English language IQCODE seemingly hav-
ing improved accuracy. However differences were modest and it
seems likely that some of these difference will relate to differing
study methodologies and populations rather than the scale itself.
Nonetheless we should be mindful of potential language effects in
interpreting the pooled analysis and future studies should detail
the language(s) of administration of tests employed.
We restricted our analysis to the healthcare setting of “community
based studies”. This setting and terminology was chosen prior to
searching and review of the literature. Our intention was to assess
those studies where participants had not been included on the basis
of cognitive testing or symptoms and we suspected that included
studies would have a population level assessment methodology.
Across the literature describing IQCODE, the “community” set-
ting proved difficult to operationalize and included a number of
differing population sampling methods and study types. Certain
included studies could be criticised for not conforming to usual
definitions of unselected, community dwelling older adults (for
example one study was of ex-servicemen only). We included all
community based studies if participants were not selected on the
basis of a factor that may relate to dementia or cognitive func-
tioning. One study, although community based, included stroke
survivors only. Clearly this group may differ from a non-stroke
population and we explored this using sensitivity analyses. In fact,
the test accuracy of IQCODE was similar comparing stroke and
non-stroke, albeit confidence intervals were necessarily larger.
Even where papers seemed to have a population based sampling
frame, the prevalence of dementia was unexpectedly high and we
must be cautious in our interpretation of these data. For unselected
community assessment we would expect a prevalence of demen-
tia in keeping with previous population estimates (5% of adults
age over 60 years; 6% to 7% of adults aged over 65 years). Only
one of our included papers (Mackinnon 2003) had proportions
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with dementia in this range. One study had a younger popula-
tion and a high prevalence of dementia suggesting a case-control
methodology,albeit this was not explicit in the manuscript, again
we explored the effect of removing this potentially unrepresenta-
tive study with sensitivity analyses and found little difference to
pooled estimates with exclusion of the paper.
In many of the included studies there was substantial potential
for bias and reporting quality was suboptimal. In general, authors
gave sufficient detail and were robust in their clinical dementia as-
sessment (reference standard); however methodology and report-
ing of patient sampling and use of IQCODE could be improved.
Assessment of quality is dependent on adequate reporting and
there were many examples where QUADAS scoring was compli-
cated by insufficient detail. One example is the blinding of de-
mentia assessors to IQCODE data, particularly as dementia diag-
nosis is often partly predicated on information from informants.
We hope that the proposed dementia specific reporting guidance
of STARDdem may improve quality in future studies that use de-
mentia as reference standard.
Strengths and weaknesses of the review
The strength of this review was its focused study question and
setting. This review was limited to studies of community dwelling
adults. While this approach avoids heterogeneity that may be in-
troduced by test ’setting’ it does limit applicability to other settings
and we should not extrapolate the data presented in this review to
hospital or primary care populations. Reviews of the test accuracy
of IQCODE in other settings and of the test accuracy of other di-
rect and informant tests are planned as separate Cochrane reviews.
We performed a comprehensive and sensitive literature search, en-
compassing cross-disciplinary electronic databases and test accu-
racy specific resources. Our primary search was complemented by
contact with other authors working in the field and we are grateful
for all the helpful responses we received. We did not limit by lan-
guage of paper and this proved to be important as studies of IQ-
CODE were international and several papers required translation.
An unexpected finding was the modest numbers of studies de-
scribing IQCODE accuracy in community settings from United
Kingdom and North America.
Due to themodest numbers of papers, we pooled data for our sum-
mary analysis across various forms of IQCODE. Our comparative
analysis would suggest that 16 and 26 item IQCODE have similar
test accuracy, however language of administration may influence
properties and as a result our summary data must be interpreted
with some caution.
We endeavoured to be as robust as possible in our assessment of
included studies. Our approach to risk of bias assessment was in-
formed by a short life working group that met to define relevant
andworkable anchoring statements and definitions of criteria (Ap-
pendix 9). As we felt that assessment of quality should include a
measure of quality of reporting we also assessed the included pa-
pers using the STARD approach (Appendix 7).
Important clinical and demographic details that could impact on
the interpretation of our IQCODE data were not consistently re-
ported and we could not describe the effect of factors such as na-
ture of the informant and severity of dementia. For translating test
accuracy studies to clinical practice, an approach that describes
numbers who could not be tested with index and reference stan-
dard is often useful (i.e. an intention to diagnose approach with
a two by three or three by three table; rather than the standard
two by two table) (Schuetz 2012). We did not collect data in this
format and at present we do not have techniques to allow pooling
of such data.
We await the results of ongoing systematic reviews and meta-anal-
yses of other dementia assessment strategies (many of which are
being completed by the Cochrane Dementia and Cognitive Im-
provememt Group) before we can begin to compare assessments
and suggest the optimal tests for a particular patient group or clin-
ical indication.
Applicability of findings to the review question
We found studies relevant to our focused study question and were
able to give summary estimates for certain of our pre-specified
co-variates of interest.. Our primary objective was to determine
the diagnostic accuracy of the informant based questionnaire IQ-
CODE, for detection of all cause (undifferentiated) dementia in
community-dwelling adults and we provide summary data that
hopefully will help clinicians and policy makers understand the
properties of IQCODE as an initial assessment in this setting.
A priori we had defined a number of subgroup and sensitivity
analyses, the limitednumber of includedpapers precludedmany of
these analyses andwe have not definitively answered our secondary
questions of describing the effect of age or dementia diagnosis
on test accuracy metrics. Further potential heterogeneity will be
introduced by the “stage”/severity of dementia at time of diagnosis,
as diagnosis will be easier in advanced disease than in early disease.
No included studies gave data on severity of diagnosis that would
allowus to describe this effect and so based on available datawe can
make no specific comment on use of IQCODE in, for example,
early stage dementia.
When planning the analysis we had conceptualised the “commu-
nity” setting as being closest to unselected, population screening.
Most of the included papers, while fulfilling our criteria for “com-
munity”, still described selected populations. It may be that this
is of only minor consequence, as test accuracy of IQCODE was
similar even when comparing highly selected groups (for example
stroke survivors) to the pooled result.
A U T H O R S ’ C O N C L U S I O N S
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Implications for practice
Accepting the limitations of included studies and the potential for
baises, results were fairly consistent across the studies and allow
us to give some guidance on the use of IQCODE. Published data
suggest that for initial assessment of dementia in older adults the
IQCODE with cut-points of 3.3 to 3.6 could be used, however as
a single assessment tool IQCODE properties may not be suited to
population level screening. We extrapolated the IQCODE sum-
mary accuracy data to a United Kingdom context as exemplar and
can see that using IQCODE exclusively will lead to substantial
false positive diagnosis. Given the public perception of dementia,
it is arguable that the distress caused by assigning a dementia label
to a person without the disease is greater than the potential harm
of initially missing dementia on screening. These are important
concepts that need to be considered if large scale cognitive screen-
ing is to be introduced.
The choice of a screening tool or triage tool for cognitive assess-
ment will not only be driven by test accuracy. Strengths of the
IQCODE from a clinician or healthcare perspective are that it is
copyright free; available in many languages; and relatively quick
and easy to complete. In general, informant-based assessments that
do not rely on direct patient testing can capture change over time
and are less prone to social-cultural biases (Jorm 2000A; Larner
2013). These are all factors that make IQCODE attractive as an
initial assessment tool and explain why it is popular in its clinical
and research use.
Our analyses of heterogeneity suggest that 26 and 16-item IQ-
CODE have similar test accuracy. It would seem sensible to rec-
ommend the short version of IQCODE as administration time
or burden is less with comparable accuracy. Other short form ver-
sions of IQCODE have been described, at present there are insuf-
ficient data available to recommend use of these other modified
IQCODE formats.
There was a trend, albeit not reaching significance, to suggest that
the language of administrationmay impact on IQCODEaccuracy.
Our findings do not imply that certain languages of assessment
are more or less accurate. The safest interpretation of these data is
as a reminder that translating IQCODE items to other languages
needs to be sensitive to idioms and cultural nuances. We would
encourage assessors using a non-English language IQCODE to
ensure that any translation and validation process has been suitably
robust.
As a single test review, our data do not allow us to comment on
how the IQCODE performs in relation to other tests. Given the
large number of assessment tools potentially available, this is the
question that may be of most interest to clinicians. In many papers
and in clinical practice, the information from IQCODE is often
used in tandemwith a direct patient cognitive assessment tool such
as MMSE. While combining instruments is intuitively attractive,
at present we do not have a systematic review of the properties of
this approach.
Implications for research
Our pooled analysis gives a large test population and the associated
estimates of diagnostic accuracy are reasonably robust. However,
we still encourage further study of the properties of IQCODE. As
an example, despite our focused study question around commu-
nity setting, the included studies in our review were largely not
typical of an unselected, older adult population. The ideal study
would involve stratified sampling and testing based, for example,
on census data, such approaches have been used in seminal work
describing the epidemiology of dementia (Ferri 2005).
IQCODE test accuracy was maintained comparing 26 and 16-
item formats. IQCODE versions with even fewer than 16 items
have been described, although numbers were too small for pooled
analysis in this review. In practice a brief assessment tool is an
attractive option if diagnostic accuracy can be maintained. We
would recommend further study of shortened (less than 16-item)
IQCODE properties.
Our review had a deliberately focused agenda and our data do not
allow us to extrapolate the diagnostic properties of IQCODE to
other healthcare settings. We recognise that dementia assessment
with additional informant interview is common in primary care
and hospital settings and reviews of the IQCODE when used in
these settings are now required. We have alluded to the need for
comparative studies of various tools used alone or in combination.
The ongoing body of work by the Cochrane group describing the
test accuracy of commonly used direct and indirect tests will offer
a substrate for future indirect comparative meta-analysis.
Our assessments of reporting quality and risk of bias are concern-
ing but in keeping with results from other areas of dementia re-
search. We urge dementia researchers to work towards improved
consistency in both methodology and reporting to assist future
reviews of the diagnostic accuracy of tests. The use of dementia-
specific guidance such as the proposed STARDdem initiative may
assist future trialists.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Jorm 1994
Study characteristics
Patient sampling Community sampling (unspecified), enriched with care-home residents
Patient characteristics and set-
ting
Community (n=945) and care-home dwelling older adults (n=100) approached; n=684 included
Community setting
Index tests IQCODE 16 and 26 item, English language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM IIIr, informed by the Canberra Interview for the Elderly
Flow and timing Of 1045 potential subjects, 769 had an informant; of this group a clinical diagnosis was possible in
684.Timingnot applicable as cross-sectional, contemporaneous IQCODEanddementia assessment
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Jorm 1994 (Continued)
If a threshold was used, was it
pre-specified?
No
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
Unclear
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
Yes
High
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Yes
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Jorm 1996 (psychiatry)
Study characteristics
Patient sampling Subjects were ex-servicemen enrolled in a separate prospective study
Patient characteristics and set-
ting
Community-dwelling ex-servicemen (n=144)
Community setting
Index tests IQCODE 16 and 26 items, English language
Target condition and reference
standard(s)
Clinical dementia diagnosis using ICD9
Flow and timing Of 209 potential subjects,144 had an informant and were included. Timing not applicable as cross-
sectional, contemporaneous IQCODE and dementia assessment
Comparative
Notes These subjects were assessed by a psychiatrist
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
High
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
Unclear
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Jorm 1996 (psychiatry) (Continued)
pendent study
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
No
Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Unclear
Kathriarachi 2001
Study characteristics
Patient sampling Stratified community sampling, using census data and door to door assessment in a semi-urban
setting
Patient characteristics and set-
ting
Community-dwelling older adults (n=37)
Community setting
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Kathriarachi 2001 (Continued)
Index tests IQCODE 26 item, Sinhalese language
Target condition and reference
standard(s)
Clinical diagnosis of dementia following psychiatrist’s review
Flow and timing Of 1400 potential subjects,40 were “randomly” selected for assessment and 37 assessed. Timing not
applicable as cross-sectional, contemporaneous IQCODE and dementia assessment
Comparative
Notes Low numbers included and high prevalence of dementia
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
No
Unclear
DOMAIN 3: Reference Standard
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Kathriarachi 2001 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
No
Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
No
Were missing IQCODE results
or un-interpretable IQCODE
results reported
No
Law 1995
Study characteristics
Patient sampling Age stratified sample of all community residents
Patient characteristics and set-
ting
Randomly selected community-dwelling adults (n=237)
Community setting
Index tests IQCODE 26 item, French language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM IIIr
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Law 1995 (Continued)
Flow and timing Of 1800 potential subjects, 454 had psychiatric assessment of this group 364 had suitable informants
and 237 were included. Timing not applicable as cross-sectional, contemporaneous IQCODE and
dementia assessment
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Law 1995 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Yes
Mackinnon 2003
Study characteristics
Patient sampling Probability sample of older adults (age > 70 years) drawn from electoral data
Patient characteristics and set-
ting
Probability sampling of community cohort (n=646)
Community setting
Index tests IQCODE 26 and 16 item, English language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM IIIr
Flow and timing Of 945 potential subjects,694 had an informant and 646 were included. Timing not applicable as
cross-sectional, contemporaneous IQCODE and dementia assessment
Comparative
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Mackinnon 2003 (Continued)
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
Yes
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Were sufficient details of de-
mentia diagnostics given for the
Yes
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Mackinnon 2003 (Continued)
assessment to be repeated in an
independent sample
High
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Unclear
Morales 1995
Study characteristics
Patient sampling Random selection of community-dwelling older adults (age > 65) from census data with initial door
to door assessment
Patient characteristics and set-
ting
Community-dwelling adults (n=68)
Community setting
Index tests IQCODE 26 and 17 item, Spanish language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM IIIr
Flow and timing Of 352 potential subjects, 257 agreed to assessment; 135 completed assessment and data from
68 with suitable informant information were included. Timing not applicable as cross-sectional,
contemporaneous IQCODE and dementia assessment
Comparative
Notes Subjects withmoderate to severe dementia were not included, so the study assesses IQCODE against
“mild” dementia clinical diagnosis
Methodological quality
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Morales 1995 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
High
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
Yes
Unclear
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Morales 1995 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Unclear
Morales 1997 (rural)
Study characteristics
Patient sampling Community sampling stratified by age/sex/place of residence with door to door assessment
Patient characteristics and set-
ting
Community (rural) dwelling adults (n=160)
Index tests IQCODE 26 item, Spanish language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM IIIr
Flow and timing Data on numbers assessed and not included are not given. Timing not applicable as cross-sectional,
contemporaneous IQCODE and dementia assessment
Comparative
Notes This paper presents two separate cohorts; these data refer to those living in a rural setting
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
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Morales 1997 (rural) (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Morales 1997 (rural) (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Yes
Morales 1997 (urban)
Study characteristics
Patient sampling Community sampling stratified by age/sex/place of residence with door to door assessment
Patient characteristics and set-
ting
Community (urban) dwelling adults (n=97)
Community setting
Index tests IQCODE 26 item, Spanish language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM IIIr
Flow and timing Data on numbers assessed and not included are not given. Timing not applicable as cross-sectional,
contemporaneous IQCODE and dementia assessment
Comparative
Notes This paper presents two separate cohorts; these data refer to those living in an urban setting
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Morales 1997 (urban) (Continued)
High
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
No
Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
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Morales 1997 (urban) (Continued)
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Yes
Senanorong 2001
Study characteristics
Patient sampling “Population” study, no further detail given
Patient characteristics and set-
ting
Community-dwelling older adults (n=160)
Community setting
Index tests IQCODE 16 and 3 item, Thai language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM IV
Flow and timing Data on numbers assessed and not included are not given. Timing not applicable as cross-sectional,
contemporaneous IQCODE and dementia assessment
Comparative
Notes This study present two cohorts these data are from “normal eduction” group. Numbers of dementia
cases suggest a case-control methodology was used but this is not specified in methodology
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Unclear
Did the study avoid inappropri-
ate exclusions?
Unclear
High
DOMAIN 2: Index Test All tests
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Senanorong 2001 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
No
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
No
Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Unclear
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Unclear
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Senanorong 2001 (Continued)
Srikanth 2006
Study characteristics
Patient sampling Community-based study of all non-aphasic stroke survivors from period 1998-1999 resident in an
urban setting
Patient characteristics and set-
ting
Community-dwelling stroke-survivors (n=79)
Community setting
Index tests IQCODE 16 item, English language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM IV
Flow and timing Of 99 subjects, 88 were eligible for assessment and IQCODE data were available for 79
Comparative
Notes These subjects are all stroke-survivors
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
High
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Srikanth 2006 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
Unclear
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
Yes
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Were missing IQCODE results
or un-interpretable IQCODE
results reported
Yes
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Yamada 2011
Study characteristics
Patient sampling Community study, sampling method not clear
Patient characteristics and set-
ting
Community-dwelling older adults who were participants in another study (n=423)
Index tests IQCODE 26 item, Japanese language
Target condition and reference
standard(s)
Clinical dementia diagnosis using DSM
Flow and timing Unclear
Comparative
Notes Abstract data only
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Were sufficient details given on
IQCODE application for the
test to be repeated in an inde-
pendent study
No
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Yamada 2011 (Continued)
High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Were sufficient details of de-
mentia diagnostics given for the
assessment to be repeated in an
independent sample
No
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Unclear
Were missing IQCODE results
or un-interpretable IQCODE
results reported
No
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abreu 2008 Hospital setting
Butt 2008 Data on less than 10 participants
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(Continued)
Cherbuin 2008 No new data
de Jonge 1997 Data not suitable for analysis
Dekkers 2009 Data not suitable for analysis
Diefeldt 2007b Repeat data set
Diesfeldt 2007 No dementia diagnosis reference standard
Ehrensperger 2010 Uses unvalidated (two-year) IQCODE
Farias 2002 No dementia diagnosis reference standard
Finneli (abstract) Data not suitable for analysis
Fuh 1995 Case-control
Garcia 2002 Hospital setting
Goncalves 2011 Hospital setting
Hancock 2009 Hospital setting
Harwood 1997 Hospital setting
Hayden 2003 <10 IQCODE
Henon 2001 Uses a delayed verification analysis
Isella 2002 Uses a delayed verification analysis
Isella 2006 Data not suitable for analysis
Jorm 1989 Data not suitable for analysis
Jorm 1989b No dementia diagnosis reference standard
Jorm 1991 Hospital setting
Jorm 1996 (Age and Ageing No dementia diagnosis reference standard
Jorm 1997 No new data
Jorm 2000 No dementia diagnosis reference standard
Jorm 2003 No new data
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(Continued)
Jorm 2004 No new data
Khachaturian 2000 No IQCODE index test data
Knaefelc 2003 Hospital setting
Krogseth 2011 Uses a delayed verification analysis
Larner 2010 Looks at diagnosis accuracy comparing two dementia types rather than dementia or no dementia
dichotomy
Larner 2013 Review article
Li 2012 No dementia diagnosis reference standard
Louis 1999 Uses a delayed verification analysis
Mackinnon 1998 Hospital setting
Mimori (abstract) No new data
Morales-Gonzalez 1992 Hospital setting
Mulligan 1996 Hospital setting
Narasimhalu 2008 Hospital setting
Ozel-kizel 2010 Hospital setting
Peroco 2009 Hospital setting
Potter 2009 Data not suitable for analysis
Razavi 2011 Hospital setting
Ritchie 1992 No IQCODE data
Rodriguez-Molinero 2010 No dementia diagnosis reference standard
Rovner 2012 Data not suitable for analysis
Sanchez 2009 No dementia diagnosis reference standard
Schofield 2006 Data not suitable for analysis
Sikkes 2010 Hospital setting
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(Continued)
Siri 2006 Hospital setting
Starr 2000 No dementia diagnosis reference standard
Tang 2003 Hospital setting
Thomas 1994 Hospital setting
Tokuhara 2006 Primary care setting
Wierderholt 1999 Data not suitable for analysis
Wolfe 2009 No dementia diagnosis reference standard
Zevallos-Bustamente 2003 Hospital setting
Zhang 2003 Data not suitable for analysis
Zhou 2002 Hospital setting
Zhou 2003 Repeat data set
Zhou 2004 Repeat data set
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
3 accuracy of IQCODE at 3.3
threshold or nearest (16 and 26
item included)
11 2644
4 accuracy of IQCODE at 3.3
threshold (16 and 26 item
IQCODE included)
6 1232
5 accuracy of IQCODE at 3.4
threshold (16 and 26 item
IQCODE included)
3 988
6 accuracy of IQCODE at 3.5
threshold (16 and 26 item
IQCODE included)
3 1144
7 accuracy of IQCODE at 3.6
threshold (16 and 26 item
IQCODE included)
3 1215
8 16 item IQCODE 3.3 threshold 2 763
9 16 item IQCODE 3.4 threshold 3 988
10 16 item IQCODE 3.5
threshold
1 684
11 16 item IQCODE 3.6
threshold
1 646
12 26 item IQCODE 3.3
threshold
5 1153
13 26 item IQCODE 3.4
threshold
1 674
14 26 item IQCODE 3.5
threshold
2 460
15 26 item IQCODE 3.6
threshold
2 569
16 all IQCODE studies at 3.
3 threshold with Srikanth
removed
5 1153
17 all IQCODE studies at 3.4
threshold with Senanorong
removed
2 828
18 all IQCODE studies at 3.5
threshold with Senanorong
removed
3 1144
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A D D I T I O N A L T A B L E S
Table 1. Summary of test accuracy at study level
Study ID Participants (n) Primary threshold Sensitivity (%) Specificity (%)
Jorm 1994 684 3.4 77 86
Jorm (psychiatry) 1996 144 3.3 91 62
Kathriarachi 2001 37 3.5 71 83
Law 1995 237 3.6 75 98
Mackinnon 2003 646 3.6 67 93
Morales 1995 68 3.3 86 92
Morales (rural) 1997 160 3.3 82 90
Morales (urban) 1997 97 3.3 83 83
Senanorong 2001 160 3.5 85 92
Srikanth 2006 79 3.3 88 63
Yamada 2011 423 3.6 80 85
Table 2. Age of participants in included studies
Study name Mean age (yrs) SD Range (yrs)
Jorm 1994 - - -
Jorm 1996 (psychiatry) 72.9 - 66 - 83
Kathriarachi 2001 - - (Recruited >65yrs only)
Law 1995 80.7 6.5 67 - 97
Mackinnon 2003 76.5 - 70 - 97
Morales 1995 73.1 5.2 65 - 86
Morales 1997 (urban) (urban) 75.2 6.1 66 - 92
Morales 1997 (urban) (rural) 73.5 8.2 61 - 96
Senanorong 2001 65.7 5.0 52 - 85
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Table 2. Age of participants in included studies (Continued)
Srikanth 2006 69.0 14.4 -
Yamada 2011 - - -
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
All differences between the protocol and review are described in the main body of the text. A priori we had planned a number of
covariate and sensitivity analyses, however the data set was limited in numbers of studies and studies were too heterogenous to allow
all of our planned analyses. We had originally planned to review the test accuracy of the 16 and 26-item IQCODE separately, however
given the modest number of studies and a comparative analysis suggesting no systematic difference between the two IQCODE formats
we used pooled data for our primary analysis.
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